Transcarent is a technology company.
Transcarent has raised $810.0M across 3 funding rounds.
Key people at Transcarent.
Transcarent has raised $810.0M in total across 3 funding rounds.
Key people at Transcarent.
Transcarent has raised $810.0M in total across 3 funding rounds.
Transcarent's investors include General Catalyst, Lightspeed Venture Partners, Vouch Insurance, Fidji Simo, 7wire Ventures, BDC Venture Capital, Flint Capital, Geodesic Capital, Frederique Dame, Ingeborg Investments, Innospark Ventures, Kinnevik.
Transcarent is a digital healthcare platform that integrates medical, pharmacy, behavioral health, and point solutions into a generative AI-powered experience, simplifying access for employees of self-insured employers and their families.[1][3][5] It serves over 20 million members across 1,700+ employers and health plans post its April 2025 $621 million merger with Accolade, offering 24/7 virtual care, personalized navigation via the WayFinding platform, medication delivery, benefits guidance, and specialized care in areas like cancer, surgery, weight management, and mental health.[2][4][5] The platform solves healthcare fragmentation, confusion, and high costs by providing unbiased, data-driven insights, clinician-supported AI, and on-demand services, operating on a subscription model that reduces total care costs while boosting utilization to ~70%.[1][3][4]
Founded in 2020 and headquartered in San Francisco (with operations noted in Denver), Transcarent emerged to address the complexity of healthcare for self-insured employers, building on early traction with a unified platform for clinical, pharmacy, and behavioral services.[1][2] Key leadership includes CEO Glen Tullman, who has driven its evolution through AI innovation and strategic expansion; the company quickly scaled by launching the WayFinding AI navigation in 2024, reaching full scale in 2025.[3][4] A pivotal moment came in April 2025 with the Accolade merger, blending Transcarent's AI WayFinding with Accolade's advocacy and virtual care to create a comprehensive "One Place for Health and Care," serving millions and partnering with entities like Evernorth for oncology benefits.[2][4]
Transcarent rides the wave of AI-driven healthcare personalization and consolidation amid rising self-insured employer demands for cost control and employee well-being, amplified by post-pandemic virtual care adoption and generative AI advancements.[3][4][6] Timing is ideal as fragmented benefits (medical, pharmacy, behavioral) drive up costs—Transcarent's integrated platform leverages employer data, EHRs, and AI to enable early interventions, aligning with market forces like value-based care and mental health prioritization.[2][4] It influences the ecosystem by pioneering responsible AI standards, merging with players like Accolade to scale to 20M+ members, and partnering for specialized programs (e.g., Evernorth oncology), pushing competitors like Firefly Health and Rezilient toward similar holistic, AI-enhanced models.[2][4][6]
Transcarent is positioned for dominance in employer-sponsored health as AI matures and consolidations accelerate, with next steps likely including deeper integrations of its WayFinding AI across chronic conditions and expanded partnerships for in-person care networks.[4][5] Trends like regulatory pushes for AI safety, rising self-insurance rates, and demand for holistic wellness will propel growth, potentially evolving its influence toward policy-shaping via alliances and full-spectrum care platforms that redefine "One Place for Health and Care."[3][6] This builds on its core mission to cut complexity, delivering the seamless experience self-insured employers demand.[1][7]
Transcarent has raised $810.0M across 3 funding rounds. Most recently, it raised $480.0M Series D in April 2025.